| Gene symbol | CD99 | Synonyms | HBA71, MIC2, MIC2X, MIC2Y, MSK5X | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | CD99 molecule (Xg blood group) | ||||
| GTO ID | GTC0870 |
| Trial ID | ChiCTR2000033989 |
| Disease | Lymphoproliferative Syndrome |
| Altered gene | CD99 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD99 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Single-center, open, single-arm clinical study of the safety and efficacy of anti-CD99 Car-T infusion in the treatment of recurrent/refractory CD99+ lymphoproliferative diseases |
| Year | 2020 |
| Country | China |
| Company sponsor | Affiliated Hospital of Xuzhou Medical University |
| Cohort 1 | |||||||
|
|||||||